IJGC Podcast

By BMJ GroupMedicine Health & Fitness

IJGC Podcast episodes

January 06, 2021 SENTOR Study: SLN in High-Risk Endometrial Cancer with Sarah Ferguson
Dr. Ferguson is a Professor in the Division of Gynecologic Oncology in the Department of Obstetrics and Gynecology at the University of Toronto and a member of the Division of Gynecologic Oncology at University Health Network/Sinai Health Systems. She is the Director of Research for the Division of Gynecologic Oncology at Princess Margaret Cancer. Dr. Ferguson completed her residency in Obstetrics and Gynecology at University of Toronto and a fellowship at Memorial Sloan-Kettering Cancer Centre in Gynecologic Oncology. Current research program includes prospective surgical trials in cervical and endometrial cancer, evaluation of patient reported outcomes and molecular characterization of endometrial cancer.
Highlights:
+ Diagnostic accuracy of SLN technique is excellent in high grade endometrial cancer – high sensitivity (low false negative rate), high NPV , DR and bilaterality rate
+ Based on this is a viable option to surgical staging in this population (clinical stage 1, high grade endometrial cancer)
+ High proportion (26%) of node positive would be missed if SLN technique was not performed
30 min
December 18, 2020 ESGO-ESTRO-ESP Endometrial Cancer Guidelines with Nicole Concin
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Nicole Concin to discuss the ESGO-ESTRO-ESP Endometrial Cancer Guidelines (https://ijgc.bmj.com/content/early/2020/12/18/ijgc-2020-002230)
44 min
December 18, 2020 Options of Urinary Diversion in Gynecologic Oncology with Carlos Martinez-Gomez
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Carlos Martinez-Gomez to discuss TOPIC. Dr. Martinez-Gomez is an author of the Lead Article for IJGC’s January 2021 issue, “Urinary diversion after pelvic exenteration for gynecologic malignancies” (https://ijgc.bmj.com/content/early/2020/11/22/ijgc-2020-002015). Dr. Martinez-Gomez is a gynecologist oncologist at Institut Universitaire du Cancer de Toulouse, France, from 2016, where he performed the ESGO fellowship program under the supervision of Drs. Gwénaël Ferron and Alejandra Martinez. His areas of interest are immunology of cervical and ovarian neoplasms, advanced ovarian cancer, reconstructive surgery after pelvic exenteration, and surgical teaching.
Highlights:
• Pelvic exenteration is a demanding surgery requiring mastery of organ removal combined with functional reconstruction
• Pelvic exenteration should be performed in high-volume referral institutions by well-trained multidisciplinary teams
• Incontinent diversion represents a good option for unfit patients or those refusing the constraints entailed by continent diversions (self-catheterization, postoperative learning, engagement)
• Postoperative complications of both types of reconstruction are comparable, but the quality of life issues would seem to support continent diversions in young and fit patients
• Continent and non-contingent techniques should be offered to patients, with a final decision based on their preferences
35 min
December 14, 2020 Reviewing the December Issue with Florencia Noll (Spanish Version)
In this episode of the IJGC Podcast, Florencia Noll discusses the contents of the December issue of IJGC in Spanish.
23 min
December 10, 2020 Reviewing the December Issue with Sadie Jones and Navya Nair (English Version)
In this issue of the IJGC Podcast, Editorial Fellows Sadie Jones and Navya Nair discuss the contents of the December issue of IJGC.
16 min
December 02, 2020 Best of 2020: Updates on Role of HIPEC in Ovarian Cancer with Oliver Zivanovic
In this rebroadcasted episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Oliver Zivanovic to discuss updates on role of HIPEC in ovarian cancer. Dr. Zivanovic is a Gynecologic Cancer Surgeon at Memorial Sloan Kettering Cancer Center, with the goal to advance the early detection and treatment of women with gynecologic cancers. His special interests include the treatment of patients with advanced stage ovarian cancer and electronic patient-reported symptom monitoring after cancer surgery.
48 min
December 02, 2020 Best of 2020: Lymphadenectomy vs. SLN: Mayo and MSK Experience with Andrea Mariani
In this rebroadcasted episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Andrea Mariani to discuss lymphadenectomy vs. SLN: Mayo and Memorial Sloan Kettering experience. Dr. Andrea Mariani is a Full Professor in the Department of Obstetrics and Gynecology, Division of Gynecologic Surgery, at Mayo Clinic in Rochester, Minnesota. His research interest is endometrial cancer with a special interest in robotic surgery. He is internationally recognized for his contributions in the advancement of surgical and postoperative treatment of endometrial cancer.
30 min
December 02, 2020 Best of 2020: Adjuvant Treatment in UPSC Limited to Endometrium with Dimitrios Nasioudis
In this rebroadcasted episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Dimitrios Nasioudis a to discuss adjuvant treatment in UPSC limited to endometrium and his article, "Adjuvant treatment for patients with FIGO stage I uterine serous carcinoma confined to the endometrium," (ijgc.bmj.com/content/early/2020…4/ijgc-2020-001379) the Lead Article in the August 2020 issue of IJGC. Dr. Nasioudis is a resident at the Hospital of the University of Pennsylvania, Philadelphia. His current interests include population science and outcomes research with an emphasis on rare gynecologic tumors.
23 min
November 30, 2020 Outcomes of UTERUS-11 Trial with Christhardt Köhler and Simone Marnitz-Schulze
In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Simone Marnitz-Schulze and Dr. Christhardt Köhler to discuss the outcomes of UTERUS-11 Trial. Drs. Marnitz-Schulze and Köhler are authors of “Surgical versus Clinical Staging prior to primary Chemoradiation in Patients with Cervical Cancer FIGO Stages IIB-IVA: Oncologic Results of a Prospective Randomized International Multicentre (Uterus-11) Intergroup Study,” which is the Lead Article of the December 2020 issue of the International Journal of Gynecological Cancer.
Highlights:
-Surgical staging prior to chemoradiation in locally advanced cervical cancer is safe, feasible, does not delay chemoradiation
-Lead to an upstaging in 33% of the patients
-Resulted into a statistically significant improvement of DFS in FIGO stage IIB patients
-Resulted into a trend for improved OS and DFS for all subgroups
-Because of high rates of distant metastases, systemic treatment has to be intensified
46 min
November 24, 2020 Transgender Patients and Cancer-Related Screening with Trinidad Labanca
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Trinidad Labanca to discuss transgender patients and cancer-related screening. Dr. Labanca is a Gynecologist at Hospital Italiano de Buenos Aires and Sexologist at the University of Buenos Aires. She has an MBA with specialization in Healthcare Management from the European Business School and specialized in Transgender Health and Sexual Confirming Genital Surgery at the Institute of Plastic Surgery Dr. Ivan Mañero, in Barcelona, Spain. She has been a WPATH member since 2015. Dr. Labanca currently works in the Department of Gender Diversity and Transgender Health at Hospital Dr. Bernardo Houssay, in Buenos Aires, Argentina.
Podcast Highlights:
1. Gynecologists and gynecologists oncologists should be involved in transgender care, understand gender diversity and promote sexual health
2. Gynecologic cancer screenings should be organ- rather than gender-based.
3. Hormone therapy and surgical status may change screening strategies.
4. There is a need of further high-quality research in the field of Transgender Health.
26 min

About IJGC Podcast

From the publisher's feed

The International Journal of Gynecological Cancer (IJGC) podcast explores the latest research on detection, prevention, diagnosis, and treatment of gynecologic malignancies. Enjoy interviews with leading experts as they discuss novel and relevant topics in the field of gynecologic cancer.